BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Behboudi S, Pereira SP. Alpha-fetoprotein specific CD4 and CD8 T cell responses in patients with hepatocellular carcinoma. World J Hepatol 2010; 2(7): 256-260 [PMID: 21161007 DOI: 10.4254/wjh.v2.i7.256]
URL: https://www.wjgnet.com/1948-5182/full/v2/i7/256.htm
Number Citing Articles
1
Yiqiong Jia, Zhen Zeng, Yuanyuan Li, Zhiwei Li, Lei Jin, Zheng Zhang, Lifeng Wang, Fu-Sheng Wang, Xue-feng Bai. Impaired Function of CD4+ T Follicular Helper (Tfh) Cells Associated with Hepatocellular Carcinoma ProgressionPLOS ONE 2015; 10(2): e0117458 doi: 10.1371/journal.pone.0117458
2
Gianluigi Giannelli, Erica Villa, Michael Lahn. Transforming Growth Factor-β as a Therapeutic Target in Hepatocellular CarcinomaCancer Research 2014; 74(7): 1890 doi: 10.1158/0008-5472.CAN-14-0243
3
Su Jong Yu, Tim F. Greten. Deciphering and Reversing Immunosuppressive Cells in the Treatment of Hepatocellular CarcinomaJournal of Liver Cancer 2020; 20(1): 1 doi: 10.17998/jlc.20.1.1
4
Angela D. Pardee, Hiroshi Yano, Aliyah M. Weinstein, Aaron A. K. Ponce, Alexander D. Ethridge, Daniel P. Normolle, Lazar Vujanovic, Gerald J. Mizejewski, Simon C. Watkins, Lisa H. Butterfield. Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinomaJournal for ImmunoTherapy of Cancer 2015; 3(1) doi: 10.1186/s40425-015-0077-x
5
Hala S. El-Rebey, Asmaa G. Abdou, Mervat M. Sultan, Shymaa H. Ibrahim, Nanis S. Holah. The Profile and Role of Tumor-infiltrating Lymphocytes in Hepatocellular Carcinoma: An Immunohistochemical StudyApplied Immunohistochemistry & Molecular Morphology 2021; 29(3): 188 doi: 10.1097/PAI.0000000000000865
6
Angela D. Pardee, Jian Shi, Lisa H. Butterfield. Tumor-Derived α-Fetoprotein Impairs the Differentiation and T Cell Stimulatory Activity of Human Dendritic CellsThe Journal of Immunology 2014; 193(11): 5723 doi: 10.4049/jimmunol.1400725
7
Helal F. Hetta, Asmaa M. Zahran, Shima G. Mansor, Mohamed O. Abdel‐Malek, Mohamed A. Mekky, Wael A. Abbas. Frequency and Implications of myeloid‐derived suppressor cells and lymphocyte subsets in Egyptian patients with hepatitis C virus‐related hepatocellular carcinomaJournal of Medical Virology 2019; 91(7): 1319 doi: 10.1002/jmv.25428
8
Wenkang Shang, Gabriel Komla Adzika, Yujie Li, Qike Huang, Ningding Ding, Bianca Chinembiri, Mohammad Sajjad Ibn Rashid, Jeremiah Ong'achwa Machuki. Molecular mechanisms of circular RNAs, transforming growth factor‐β, and long noncoding RNAs in hepatocellular carcinomaCancer Medicine 2019; 8(15): 6684 doi: 10.1002/cam4.2553
9
Yongqi Ding, Yiyang Gong, Hong Zeng, Gelin Song, Zichuan Yu, Bidong Fu, Yue Liu, Da Huang, Yanying Zhong. ZNF765 is a prognostic biomarker of hepatocellular carcinoma associated with cell cycle, immune infiltration, m6A modification, and drug susceptibilityAging 2023; 15(13): 6179 doi: 10.18632/aging.204827
10
JUN ZHOU, PING MA, JUN LI, XIAONAN CUI, WEI SONG. Improvement of the cytotoxic T lymphocyte response against hepatocellular carcinoma by transduction of cancer cells with an adeno-associated virus carrying the interferon-γ geneMolecular Medicine Reports 2016; 13(4): 3197 doi: 10.3892/mmr.2016.4884
11
Tai Hato, Andrew X Zhu, Dan G Duda. Rationally Combining Anti-VEGF Therapy with Checkpoint Inhibitors in Hepatocellular CarcinomaImmunotherapy 2016; 8(3): 299 doi: 10.2217/imt.15.126
12
RUI XU, QIBIAO WU, YUHAN GONG, YONGZHE WU, QINGJIA CHI, DA SUN. A novel prognostic target-gene signature and nomogram based on an integrated bioinformatics analysis in hepatocellular carcinomaBIOCELL 2022; 46(5): 1261 doi: 10.32604/biocell.2022.018427